Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |